Mad Money w/ Jim Cramer

Mad Money w/ Jim Cramer 1/22/24

Jan 23, 2024
Exploring building a portfolio using Fidelity Basket Portfolios and the potential exclusion of Tesla from the 'magnificent seven' stocks. Discussion on Tesla's challenges, declining value of cars, market saturation, competition from Chinese manufacturers, and need for more charging stations. Analysis of Tesla's stock decline and Catalyst Pharmaceuticals potential. Delving into potential outcomes for Catalyst and analyzing semiconductor stocks. Debating rate cuts by the Federal Reserve and its impact on the economy.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Tesla's Performance and Challenges
02:08 • 10min
3
Analysis of Tesla's stock decline, Eli Lilly's stock advance, Catalyst Pharmaceuticals, Dancing Jens and Wong, cybersecurity space, and upcoming CEO interview
12:06 • 4min
4
Catalyst's FDA-approved drug for LEMS and other acquisitions
16:20 • 4min
5
Analyzing the Potential Outcomes for Catalyst
20:23 • 4min
6
Semiconductor Stocks and Market Analysis
24:23 • 20min
7
Debating Rate Cuts and the Strength of the Economy
44:37 • 5min